Immediate protamine administration and sheath removal following percutaneous coronary intervention: A prospective study of 429 patients
Authors:
- 24 May 2002
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 56 (2) , 196-199
Abstract
We tested the approach of reversing anticoagulation following PCI and immediate sheath removal in 429 consecutive patients. On completion of the PCI, protamine was administered, and the vascular sheath was immediately removed. Stents were used in 364 patients (85%) and GP IIb/IIIa inhibitors were used in 52 patients (12%). Time to achieve hemostasis was 30 ± 17 min. Minor groin bleeding occurred in six patients. One patient required repair of femoral pseudoaneurysm. Mean creatine kinase at 8 and 16 hr post‐PCI were 129 ± 35 and 145 ± 32 units, respectively. Creatine kinase rose to > 3 times normal in 12 out of 350 patients (3.4%). Prior to 48 hr, eight patients (1.9%) required emergency PCI or coronary bypass surgery. Follow‐up at 30 days observed no deaths and only three target vessel revascularizations (0.7%). In conclusion, immediate reversal of anticoagulation and sheath removal after PCI is safe and feasible. Cathet Cardiovasc Intervent 2002;56:196–199.Keywords
This publication has 18 references indexed in Scilit:
- Minimal heparinization in coronary angioplasty—how much heparin is really warranted?The American Journal of Cardiology, 2000
- Two hour ambulation after coronary angioplasty and stenting with 6 F guiding catheters and low dose heparinHeart, 1999
- Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockadeThe Lancet, 1998
- Prolonged heparin after uncomplicated coronary interventions: A prospective, randomized trialAmerican Heart Journal, 1998
- Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockadeThe Lancet, 1998
- In-Laboratory Removal of Femoral Sheath Following Protamine Administration in Patients Having Intracoronary Stent ImplantationThe American Journal of Cardiology, 1997
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- Low-Dose Heparin for Routine Coronary Angioplasty and StentingThe American Journal of Cardiology, 1996
- Peripheral vascular complications following coronary interventional proceduresClinical Cardiology, 1995
- Randomized prospective evaluation of prolonged versus abbreviated intravenous heparin therapy after coronary angioplastyJACC, 1994